- Home
- MIST vs SOL Comparison
MIST vs SOL Comparison
Compare MIST & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- SOL
- Stock Information
- Founded
- MIST 2003
- SOL 2005
- Country
- MIST Canada
- SOL United States
- Employees
- MIST N/A
- SOL N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- MIST Health Care
- SOL Technology
- Exchange
- MIST Nasdaq
- SOL Nasdaq
- Market Cap
- MIST 100.3M
- SOL 104.0M
- IPO Year
- MIST N/A
- SOL 2008
- Fundamental
- Price
- MIST $1.98
- SOL $2.04
- Analyst Decision
- MIST Strong Buy
- SOL Buy
- Analyst Count
- MIST 3
- SOL 3
- Target Price
- MIST $13.00
- SOL $3.83
- AVG Volume (30 Days)
- MIST 636.8K
- SOL 277.9K
- Earning Date
- MIST 11-12-2024
- SOL 11-14-2024
- Dividend Yield
- MIST N/A
- SOL N/A
- EPS Growth
- MIST N/A
- SOL N/A
- EPS
- MIST N/A
- SOL N/A
- Revenue
- MIST N/A
- SOL $102,489,000.00
- Revenue This Year
- MIST N/A
- SOL N/A
- Revenue Next Year
- MIST N/A
- SOL $46.42
- P/E Ratio
- MIST N/A
- SOL N/A
- Revenue Growth
- MIST N/A
- SOL 25.98
- 52 Week Low
- MIST $1.12
- SOL $1.41
- 52 Week High
- MIST $2.75
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- MIST 49.21
- SOL 51.14
- Support Level
- MIST $1.92
- SOL $1.86
- Resistance Level
- MIST $2.07
- SOL $2.17
- Average True Range (ATR)
- MIST 0.20
- SOL 0.14
- MACD
- MIST -0.03
- SOL 0.00
- Stochastic Oscillator
- MIST 9.41
- SOL 40.91
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.